Patents Assigned to ChronoSyn, LLC
  • NUTRACEUTICAL COMPOSITION AND DOSING REGIMEN
    Publication number: 20180193312
    Abstract: The present invention is a nutraceutical formulation, intended for oral administration, comprising co-administered if not co-formulated melatonin together with at least one of strontium, Vitamin D, and Vitamin K or their analogues. The nutraceutical combination or formulation is designed to be taken by mouth within about two hours prior to bedtime, and in fact should not be taken at any other time. The combination therapy gives new and unexpectedly improved results compared to the administration of melatonin alone.
    Type: Application
    Filed: July 25, 2017
    Publication date: July 12, 2018
    Applicant: ChronoSyn, LLC
    Inventors: Mark Herbert Swanson, Paula A Witt-Enderby